Results 121 to 130 of about 399,722 (264)

Somatostatin analogs in endothelial dysfunction. [PDF]

Am J Physiol Endocrinol Metab
Barabutis N.
europepmc   +1 more source

Testosterone and endothelial dysfunction [PDF]

Nature Reviews Urology, 2019
openaire   +2 more sources

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

Advanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu, Mengtao Sun, Lusheng Li, Jieqiong Wang, Shibiao Wan   +4 more
wiley   +1 more source

What else matters for endothelial dysfunction biomarkers in hemodialysis patients? [PDF]

Ren Fail
Zhao Y, Wang W, Yang Z, Pu G, Zhang L, Zhao C.   +5 more
europepmc   +1 more source

Ultrasound‐Activated Bifunctional Piezoelectric Hydrogel Dressings Promote Infected Wound Healing via Regulating Angiogenesis and Lymphangiogenesis

Advanced Science, EarlyView.
This study developed a double‐network hydrogel with piezoelectric properties, exhibiting excellent antibacterial activity and promoting fibroblast migration, angiogenesis, and lymphangiogenesis through piezoelectric stimulation, thereby accelerating the healing of infected chronic wounds.
Xiang Li, Zhen Ding, Zhihua Liu, Hao Chen, Jianyang Shan, Yanxuan Shao, Yaling Yu, Gen Wen   +7 more
wiley   +1 more source

The interplay between neuroinflammation and endothelial dysfunction in cerebral small vessel disease. [PDF]

Front Immunol
Jin C, Zhao Y.
europepmc   +1 more source

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

Advanced Science, EarlyView.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma, Rui Guo, Dongfeng Niu, Yufei Song, Zhenyao Zhang, Xiangxi Meng, Lili Mao, Haifeng Huang, Hua Zhu, Zhi Yang, Teli Liu   +10 more
wiley   +1 more source

Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome. [PDF]

Sci Rep
Oestreich M, Schmidt M, Dittrich J, Baber R, Gaudl A, Reinicke M, Willenberg A, Wirkner K, Then Bergh F, Fricke C, Rockstroh A, Fertey J, Ulbert S, Lehmann J, Müller C, Matijevic M, Zeynalova S, Engel C, Löffler M, Isermann B, Ceglarek U, Biemann R.   +21 more
europepmc   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Editorial: Endothelial dysfunction in metabolic disorders: mechanisms, biomarkers, and emerging therapeutics. [PDF]

Front Pharmacol
Gangaraju R.
europepmc   +1 more source